Robert Tjian - Net Worth and Insider Trading

Robert Tjian Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Tjian owns 1 companies in total, including Nurix Therapeutics Inc (NRIX) .

Click here to see the complete history of Robert Tjian’s form 4 insider trades.

Insider Ownership Summary of Robert Tjian

Ticker	Comapny	Transaction Date	Type of Owner
NRIX	Nurix Therapeutics Inc	2020-07-23	director

Robert Tjian Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert Tjian Ownership Network

Ownership Network List of Robert Tjian

No Data

Ownership Network Relation of Robert Tjian

Robert Tjian Owned Company Details

What does Nurix Therapeutics Inc do?

Who are the key executives at Nurix Therapeutics Inc?

Robert Tjian is the director of Nurix Therapeutics Inc. Other key executives at Nurix Therapeutics Inc include General Counsel Christine Ring , Chief Financial Officer Houte Hans Van , and Chief Scientific Officer Gwenn Hansen .

Nurix Therapeutics Inc (NRIX) Insider Trades Summary

Over the past 18 months, Robert Tjian made no insider transaction in Nurix Therapeutics Inc (NRIX). Other recent insider transactions involving Nurix Therapeutics Inc (NRIX) include a net sale of 45,727 shares made by Christine Ring , a net sale of 76,829 shares made by Houte Hans Van , and a net sale of 12,402 shares made by Gwenn Hansen .

In summary, during the past 3 months, insiders sold 62,735 shares of Nurix Therapeutics Inc (NRIX) in total and bought 0 shares, with a net sale of 62,735 shares. During the past 18 months, 135,300 shares of Nurix Therapeutics Inc (NRIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 135,300 shares.

Nurix Therapeutics Inc (NRIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nurix Therapeutics Inc Insider Transactions

No Available Data

Robert Tjian Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Tjian. You might contact Robert Tjian via mailing address: C/o Nurix Therapeutics, Inc., 1700 Owens Street, Suite 205, San Francisco Ca 94158.

Discussions on Robert Tjian

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.